Abstract: Alopecia areata is believed to be an autoimmune disease resulting from a breach in the immune privilege of the hair follicles causing non scarring hair loss. Methods: our study included 40 patients from may 2019 to july 2022 diagnosed clinically, dermatoscopically and pathologically as alopecia areata Data were enrolled from department of dermatology and venereology, Al-Hussein hospital.
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Mac Donald Hull and Norris grading system
Timeframe: 4 weeks after the end of treatment
Scoring of texture of regrown hair
Timeframe: after each session and 4 weeks after the end of treatment
Scoring of pigmentation of regrown hair
Timeframe: after each session and 4 weeks after the end of treatment
Scoring for density of hair regrowth
Timeframe: after each session and 4 weeks after the end of treatment
Scoring of overall response at the end of the study
Timeframe: after each session and 4 weeks after the end of treatment
histopathological changes
Timeframe: after each session and 4 weeks after the end of treatment
trichoscopic parameters
Timeframe: after each session and 4 weeks after the end of treatment